CardioMech
ID: 5842055CardioMech is a Norwegian based company focused on providing a transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve.
5
Funding Rounds
$52.4m
Money raised
Recent Funding Rounds
Overview
CardioMech is a Norwegian based company focused on providing a transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve.
- Website:
- Business model: B2B
- Headquarters: Trondheim
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company CardioMech has raised a total of $38.17m in funding over 5 rounds.
Key Insights:
- CardioMech January 2024 Series A Funding Round: $13m
- CardioMech Funding Round, April 2022: $6.17m
- CardioMech August 2020 Series A Funding Round: $19m
- CardioMech AS funding round, August 2019: $5m
- CardioMech AS funding round, August 2020: $9.2m
Industries
CardioMech is active in the following industries: